M&T Bank Corp Purchases 35,083 Shares of Encompass Health Corporation $EHC

M&T Bank Corp lifted its position in shares of Encompass Health Corporation (NYSE:EHC) by 1,781.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 37,052 shares of the company’s stock after acquiring an additional 35,083 shares during the period. M&T Bank Corp’s holdings in Encompass Health were worth $3,933,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also made changes to their positions in EHC. Alliancebernstein L.P. increased its stake in Encompass Health by 23.4% in the third quarter. Alliancebernstein L.P. now owns 2,515,878 shares of the company’s stock valued at $319,567,000 after acquiring an additional 476,564 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in Encompass Health by 0.5% during the third quarter. Dimensional Fund Advisors LP now owns 1,616,178 shares of the company’s stock worth $205,279,000 after purchasing an additional 7,349 shares during the last quarter. Raymond James Financial Inc. boosted its holdings in shares of Encompass Health by 34.8% in the 3rd quarter. Raymond James Financial Inc. now owns 1,541,336 shares of the company’s stock valued at $195,780,000 after purchasing an additional 397,694 shares in the last quarter. JPMorgan Chase & Co. increased its stake in shares of Encompass Health by 5.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,410,335 shares of the company’s stock valued at $179,141,000 after purchasing an additional 70,387 shares during the last quarter. Finally, Millennium Management LLC increased its stake in shares of Encompass Health by 140.0% in the 3rd quarter. Millennium Management LLC now owns 1,223,665 shares of the company’s stock valued at $155,430,000 after purchasing an additional 713,738 shares during the last quarter. Institutional investors and hedge funds own 97.25% of the company’s stock.

Encompass Health Stock Performance

Shares of Encompass Health stock opened at $101.96 on Monday. The company’s 50 day moving average price is $103.66 and its two-hundred day moving average price is $108.04. The firm has a market capitalization of $10.14 billion, a P/E ratio of 18.40, a P/E/G ratio of 1.95 and a beta of 0.75. Encompass Health Corporation has a fifty-two week low of $92.77 and a fifty-two week high of $127.99. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.08 and a quick ratio of 1.08.

Encompass Health (NYSE:EHC) last announced its quarterly earnings results on Thursday, February 5th. The company reported $1.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.29 by $0.17. Encompass Health had a net margin of 9.54% and a return on equity of 18.20%. The company had revenue of $3.09 billion during the quarter, compared to the consensus estimate of $1.54 billion. During the same period in the prior year, the business earned $1.17 earnings per share. The company’s revenue for the quarter was up 9.9% compared to the same quarter last year. Encompass Health has set its FY 2026 guidance at 5.810-6.100 EPS. On average, equities analysts forecast that Encompass Health Corporation will post 5.91 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, April 15th. Shareholders of record on Wednesday, April 1st were issued a $0.19 dividend. This represents a $0.76 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend was Wednesday, April 1st. Encompass Health’s dividend payout ratio is presently 13.72%.

Insider Activity

In other news, CEO Mark J. Tarr sold 150,000 shares of the company’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $111.64, for a total value of $16,746,000.00. Following the completion of the transaction, the chief executive officer owned 377,070 shares of the company’s stock, valued at $42,096,094.80. This represents a 28.46% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Treasurer Edmund Fay sold 11,937 shares of the firm’s stock in a transaction that occurred on Monday, March 9th. The shares were sold at an average price of $107.00, for a total transaction of $1,277,259.00. Following the completion of the transaction, the treasurer owned 89,325 shares of the company’s stock, valued at approximately $9,557,775. This trade represents a 11.79% decrease in their position. The SEC filing for this sale provides additional information. 1.80% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the company. Barclays upped their price objective on Encompass Health from $150.00 to $153.00 and gave the stock an “overweight” rating in a research report on Friday, February 6th. Wall Street Zen cut Encompass Health from a “buy” rating to a “hold” rating in a research report on Saturday, April 11th. Two research analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $143.29.

Encompass Health Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.